Reglan is a prescription drug used for the treatment of acid reflux and is also sometimes prescribed for patients with diabetic gastroparesis, a disorder where the stomach takes too long to empty its contents, causing intense heartburn, nausea and vomiting.
It is marketed under the names Octamide, Maxolon, Metoclopramide, Degan, Maxeran, Primperan, and Pylomid.
Although the U.S. Food and Drug Administration (FDA) approved Reglan in 1995 for short-term use (4 to 12 weeks), 27%–29% of consumers who took Reglan for 12 months or longer have experienced symptoms related to Tardive Dyskinesia.
Tardive Dyskinesia is a neurological condition whose symptoms include:
- Jerking movements of the tongue, face, mouth, and jaw
- Involuntary movement of the hands and fingers
- Uncontrolled movement of the arms, legs, and trunk
- Uncontrolled facial grimacing
- Tongue protrusion
- Lip smacking
- Rapid eye blinking
In fact, on February 26, 2009, the FDA announced that manufacturers of Reglan (metoclopramide) must add the following black box warning to their drug labels to warn about the risks associated with its long-term or high-dose use:
“Chronic use of metoclopramide has been linked to tardive dyskinesia, which may include involuntary and repetitive movements of the body, even after the drugs are no longer taken. These symptoms are rarely reversible and there is no known treatment.”
If you or a loved one has taken Reglan and suffered any of these side-effects, you may be entitled to compensation. Call the experienced personal injury and product liability attorneys at Carr & Carr today or contact us online. For over 35 years, we have helped injured citizens obtain the care and compensation they deserve.
Tags: acid reflux, blinking, Degan, drugs, gastroparesis, GERD, grimacing, jerking movements, Maxeran, Maxolon, metoclopramide, Octamide, Primperan, Pylomid, reglan, tardive dyskinesia
